Smooth Drug Development January 2024 News Release

We are working on the following new projects:

• We have successfully passed quality control of a global company and we are finalizing a contract for data management activities in observational programs.
• A contract for a phase III study with Adalimumab was signed.
• We are signing a contract for two articles based on trial results, performed by our company. One article will be published in an international magazine.
• We were awarded with two BE projects with Duloxetine and Nimesulide by our long-term client.
• Smooth signed a contract for regulatory services in an observational program in oncology.
• A full services contract for a phase I trial with dornase alpha was signed. The trial will be conducted in Kazakhstan.

We are happy to reach the following milestones in our projects:

• Clinical part was performed in a Liraglutide trial.
• Three sites were opened in a Tegoprazan trial.
• Monitoring visits were performed in Uzbekistan in the observational program of multivitamins in pregnant and childbearing women.
• Start-up was performed in a Tadalafil trial.